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Abstract
The potential protective action of 1,4-dihydropyridine derivatives (cerebrocrast, gammapyrone, glutapyrone, and diethone)
against oxidative stress was assessed on mitochondrial bioenergetics, inner membrane anion channel (IMAC), Ca2þ-induced
opening of the permeability transition pore (PTP), and oxidative damage induced by the oxidant pair adenosine diphosphate
(ADP)/Fe2þ (lipid peroxidation) of mitochondria isolated from rat liver. By using succinate as the respiratory substrate,
respiratory control ratio (RCR), ADP to oxygen ratio (ADP/O), state 3, state 4, and uncoupled respiration rates were not
significantly affected by gammapyrone, glutapyrone, and diethone concentrations up to 100 mM. Cerebrocrast at concentrations
higher than 25 mM depressed RCR, ADP/O, state 3, and uncoupled respiration rates, but increased three times state 4 respiration
rate. The transmembrane potential (DC) and the phosphate carrier rate were also decreased. At concentrations lower than 25 mM,
cerebrocrast inhibited the mitochondrial IMAC and partially prevented Ca2þ-induced opening of the mitochondrial PTP, whereas
gammapyrone, glutapyrone, and diethone were without effect. Cerebrocrast, gammapyrone, and glutapyrone concentrations up to
100 mM did not affect ADP/Fe2þ-induced lipid peroxidation of rat liver mitochondria, while very low diethone concentrations (up to
5 mM) inhibited it in a dose-dependent manner, as measured by oxygen consumption and thiobarbituric acid reactive substances
formation. Diethone also preventedDCdissipation due to lipid peroxidation initiated by ADP/Fe2þ. It can be concluded that: none of
the compounds interfere with mitochondrial bioenergetics at concentrations lower than 25 mM; cerebrocrast was the only compound
that affected mitochondrial bioenergetics, but only for concentrations higher than 25 mM; at concentrations that did not affect
mitochondrial bioenergetics (#25 mM), only cerebrocrast inhibited the IMAC and partially prevented Ca2þ-induced opening of the
PTP; diethone was the only compound that expressed antioxidant activity at very low concentrations (#5 mM). Cerebrocrast acting
as an inhibitor of the IMAC and diethone acting as an antioxidant could provide effective protective roles in preventing mitochondria
from oxidative damage, favoring their therapeutic interest in the treatment of several pathological situations known to be associated
with cellular oxidative stress.
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1. Introduction
Cerebrocrast, gammapyrone, glutapyrone, and
diethone are four new structurally and functionally
different 1,4-dihydropyridine (DHP) derivatives
developed at the Latvian Institute of Organic
Synthesis, Riga, Latvia, and the molecular structure
of these compounds is shown in Fig. 1. Cerebrocrast
[IOS-1.1212; 2-propoxyethyl ester of 2,6-dimethyl-4-
(2-difluoromethoxyphenyl)-1,4-dihydropyridine-3,5-
dicarboxylic acid] is a neuroprotector and cognition
enhancer compound (Misa˜ne et al., 1993; Klusa,
1995; Velena et al., 1997; Klegeris et al., 2002). Its
molecule is characterized by increased lipophilicity
due to both medium length 2-propoxy-ethyl side
chains with oxa atoms in positions 3 and 5 of the DHP
ring and the combination with the difluoromethoxy-
group at position 2 of the phenyl ring which is joined
to the DHP at position 4 (Misa˜ne et al., 1993; Klusa,
1995; Velena et al., 1997; Klegeris et al., 2002). It is
considered that this lipophilic molecule is capable of
penetrating easily the blood–brain barrier, the plasma
and organelles membranes, including those of mito-
chondria (Misa˜ne et al., 1993; Klusa, 1995; Velena
et al., 1997; Klegeris et al., 2002). Gammapyrone
[IOS-1.2134; 4-(2,6-dimethyl-3,5-diethoxycarbonyl-
1,4-dihydropyridine-4-carboxamido) butyric acid] is
a neuroprotector (Misa˜ne et al., 1993), whereas
glutapyrone [IOS-1.397; disodium 2-(2,6-dimethyl-
3,5-diethoxycarbonyl-1,4-dihydropyridine-4-carbox-
amido) glutarate] is an antiarrhythmic compound
(Karpova et al., 1993; Klusa et al., 1996; Velena et al.,
1997; Briede et al., 2000). These two compounds are
members from the family of a novel type of
peptidomimetic DHP compounds (amino acid-con-
taining DHPs), designed by adding neuroprotective
amino acids (glutamic, gamma aminobutyric acid,
and others) via the carbonyl group to the DHP ring in
position 4. They differ from the classical DHP
compounds by their high water solubility and low
toxicity (Velena et al., 1997). Diethone ([1287-53-5];
2,6-dimethyl-3,5-diethoxycarbonyl-1,4-dihydropyri-
dine), a four-unsubstituted DHP molecule, is an anti-
oxidant and radioprotector compound characterized
Fig. 1. Molecular structures of cerebrocrast (A), gammapyrone (B), glutapyrone (C), and diethone (D).
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as being lipophilic and non-toxic (Ivanov et al., 1990;
Abdalla et al., 1999; Velena et al., 1999).
Cerebrocrast, gammapyrone, and glutapyrone did
not influence significantly the 45Ca2þ uptake by rat
cortical synaptosomes (Karpova et al., 1993; Misa˜ne
et al., 1993). Glutapyrone did not change the 45Ca2þ
uptake in rabbit myocardial slices or the contraction
force of isolated spontaneously beating rabbit atria
(Klusa et al., 1996). These data suggest that these
compounds lack calcium antagonist properties that are
typical of the traditional DHP (Misa˜ne et al., 1993;
Karpova et al., 1993; Klusa et al., 1996). No infor-
mation exists in the literature concerning the diethone
calcium antagonizing action. Due to their protective
properties, these DHP derivatives may be potentially
useful for the treatment of several pathological
processes, including those associated with oxidative
stress.
Oxidative stress refers to the cytotoxic effects of
reactive oxygen species (ROS) which may damage
cellular components including nucleic acids, proteins,
and membrane phospholipids, promoting cell death
(Kehrer, 1993; Halliwell and Gutteridge, 1994, 1999).
Mitochondria, whose main function is ATP synthesis
by oxidative phosphorylation, are also considered to
be the major endogenous source of cellular ROS,
under normal and pathological conditions, and
perhaps of oxidative stress in general (Lee and Wei,
2000; Murphy and Smith, 2000; Pedersen, 2000).
Mitochondria are also the cellular component most
extensively affected by increased concentrations of
ROS (Lee and Wei, 2000; Murphy and Smith, 2000;
Pedersen, 2000). Therefore, the potential protective
action of the DHP derivatives (cerebrocrast, gamma-
pyrone, glutapyrone, and diethone) may contribute to
the preservation of mitochondrial functions in several
pathological conditions associated with oxidative
stress. However, it is important to analyze the direct
effect of these compounds on mitochondrial bioener-
getics, since their interaction with mitochondrial
membranes can disturb the coupling efficiency
between oxidation and phosphorylation, promoting
bioenergetic deficits leading to the loss of several
functions vital to the survival of the cell and the
organism (Wallace and Starkov, 2000).
The purpose of this study was to investigate, firstly,
the direct effect of cerebrocrast, gammapyrone, gluta-
pyrone, and diethone on mitochondrial bioenergetics
and secondly, the antioxidant capacity of these com-
pounds on isolated liver mitochondria under severe
oxidative damage conditions. The effect of these
compounds was also tested on both the inner mito-
chondrial membrane anion channel (IMAC), which
mediates the electrophoretic transport of a wide
variety of anions and is believed to be an important
component of the volume homeostatic mechanism
(Beavis, 1992) and on the inner membrane perme-
ability transition pore (PTP), which is induced under
high matrix Ca2þ loads, oxidative stress, and depolar-
ization and is believed to contribute to cellular injury
by releasing cytochrome c and other factors able to
trigger apoptosis (O’Rourke, 2000). The interaction of
these four DHP derivatives with these channels could
be relevant to the preservation of the mitochondrial
structure and function and, consequently, to their
potential protective action.
2. Materials and methods
2.1. Animals
Male Wistar rats (250 – 350 g), housed at
22 ^ 2 8C under artificial light for 12-h light/dark
cycle and with access to water and food ad labium,
were used throughout the experiments. The experi-
ments reported here were carried out in accordance
with the National Requirements for Vertebrate
Animal Research and the European Convention for
the Protection of Animals used for Experimental and
other Scientific Purposes.
2.2. Isolation of rat liver mitochondria
Rat liver mitochondria were isolated from male
Wistar rats (6 weeks) by differential centrifugation
according to conventional methods (Gazotti et al.,
1979). After washing, the pellet was gently resus-
pended in the washing medium at a protein concen-
tration of about 50 mg ml21. Protein content was
determined by the biuret method (Gornall et al.,
1949), using bovine serum albumin as standard.
2.3. Measurement of respiratory activities
Oxygen consumption of isolated mitochondria was
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measured polarographically with a Clark oxygen
electrode connected to a suitable recorder, in a 1 ml
thermostated water-jacked, closed chamber with
magnetic stirring at 30 8C. The respiratory reaction
medium consisted of 250 mM sucrose, 10 mM
HEPES pH 7.2, 20 mM KCl, 5 mM potassium
phosphate, and 2 mM MgCl2. Mitochondria (1 mg
protein) were incubated in 1 ml reaction medium
supplemented with 2 mM rotenone (in the presence
and absence of compounds) for 3 min, before
energization with 10 mM succinate. To induce state
3 respiration, adenosine diphosphate (ADP, 150 mM)
was added. The respiratory control ratio (RCR) and
ADP to oxygen ratio (ADP/O) were calculated
according to the method previously described
(Chance and Williams, 1956), considering that the
saturation oxygen concentration was 232 nmol O2/ml
in the reaction medium at 30 8C. Uncoupled respi-
ration was initiated by the addition of 1 mM
p-trifluoromethoxyphenylhydrazone (FCCP).
2.4. Measurement of mitochondrial transmembrane
potential (DC)
The mitochondrial transmembrane potential (DC)
was measured indirectly based on the activity of the
lipophilic cation tetraphenylphosphonium (TPPþ)
using a TPPþ-selective electrode in combination
with a Ag/AgCl-saturated reference electrode as pre-
viously described (Kamo et al., 1979). Both the TPPþ
and the reference electrode were inserted into an open
glass chamber equipped with magnetic stirring and a
thermostat set at 30 8C, and were connected to a pH
meter. The signal was fed to a dual-trace potentio-
metric recorder. Mitochondria (1 mg) were incubated
in 1 ml of respiration reaction medium supplemented
with 2 mM rotenone and 3 mM TPPþ (in the presence
or absence of the compounds) for 3 min, before
energization with 10 mM succinate. The DC was
estimated as previously indicated (Kamo et al., 1979)
from the following equation: DC ¼ 59 £ logðv=VÞ2
59 £ logð10DE=59 2 1) where v, V, and DE stand for
mitochondria volume, volume of incubation medium,
and deflection of the electrode potential from the
baseline, respectively. A matrix volume of 1.1 ml/mg
of protein was assumed. No correction was made for
‘passive’ binding of TPPþ to the mitochondria mem-
branes because the purpose of the experiments was to
show relative changes in potential rather than absolute
values. As a consequence, we can anticipate some
overestimation for the DC values. Cerebrocrast,
gammapyrone, glutapyrone, and diethone did not
affect TPPþ binding to mitochondria membranes or
the electrode response.
2.5. Mitochondrial swelling
Mitochondrial osmotic volume changes were
measured by the apparent absorbance changes at
520 nm with a suitable spectrophotometer-recorder
set up. The reactions were carried out at 30 8C in
2.5 ml of the required media as indicated in the
legends to figures.
2.6. Evaluation of mitochondrial membranes
oxidative damage induced by ADP/Fe2þ
Mitochondrial membranes oxidative damage (lipid
peroxidation) was induced by using ADP and iron
(Fe2þ, FeSO4) as oxidizing agents. Mitochondria
(1 mg) were pre-incubated for 3 min at 30 8C in 1 ml
of a standard medium containing 175 mM KCl,
10 mM Tris–Cl pH 7.4 supplemented with 3 mM
rotenone (in the presence or absence of compounds) to
avoid mitochondrial respiration induced by endogen-
ous respiratory substrates. Membrane lipid peroxi-
dation was induced by adding simultaneously 1 mM
ADP and 0.1 mM FeSO4 (ADP/Fe
2þ). Iron solution
was prepared immediately before use and protected
from light. Controls were incubated at 30 8C during
the same period of time, in the absence of ADP/Fe2þ,
with or without the compounds.
Membrane lipid peroxidation was evaluated by
measuring two different parameters, oxygen con-
sumption, and thiobarbituric acid reactive substances
(TBARS) formation (Ernster and Nordenbrand,
1967). For the TBARS assay, 0.5 ml aliquots of
mitochondria suspensions, removed 10 min after the
addition of ADP/Fe2þ were added to 0.5 ml of ice
cold 40% trichloroacetic acid. Then, 2 ml of 0.67%
of aqueous thiobarbituric acid containing 0.01% of
2,6-di-tert-butyl-p-cresol was added. The mixtures
were heated at 90 8C for 15 min, cooled in ice for
10 min, and centrifuged at 850 g for 10 min. The
supernatant fractions were collected and lipid peroxi-
dation was estimated spectrophotometrically at
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530 nm. The amount of TBARS formed was calcu-
lated using a molar extinction coefficient of
1.56 £ 105 mol21 cm21 and expressed as nmol
TBARS/mg protein (Buege and Aust, 1978). When
the effect of diethone on DC dissipation induced by
lipid peroxidation was evaluated, the standard
medium was supplemented with 3 mM rotenone and
1 mg oligomycin and mitochondria were energized
with 10 mM succinate before initiation of lipid
peroxidation by the addition of ADP/Fe2þ.
2.7. Statistical analysis
All the experiments were performed using at least
four to six independent experiments with different
mitochondrial preparations. The values are expressed
as means ^ S.E. Means were compared using
ANOVA, post-test Student – Newmann – Keuls.
Statistical significance was set at p , 0:05.
2.8. Chemicals
All chemicals were obtained from Sigma, St.
Louis, MO, USA, except cerebrocrast, gammapyrone,
glutapyrone, and diethone which were synthesized
at the Latvian Institute of Organic Synthesis, 21
Aizkraukles Street, Riga, LV-1006, Latvia. Gamma-
pyrone and glutapyrone were dissolved in water.
Cerebrocrast and diethone were dissolved in absolute
dimethyl sulfoxide (DMSO). Pure solutions of DMSO
were added to controls with the highest volume used
of both compounds’ DMSO solutions [0.1% (v/v) of
the experiments final volume] and had no effects on
the measured activities.
3. Results
The effects of cerebrocrast, gammapyrone, gluta-
pyrone, and diethone on succinate-dependent respi-
ratory indexes, RCR, and ADP/O ratio of rat liver
mitochondria are shown in Fig. 2. Glutapyrone,
gammapyrone, and diethone concentration up to
100 mM, as well as cerebrocrast in the concentration
range up to 25 mM, do not significantly affect the
RCR and ADP/O. For a higher concentration range
(up to 100 mM), cerebrocrast significantly depresses
RCR and ADP/O ratio.
Fig. 3 shows the effects of cerebrocrast, gamma-
pyrone, glutapyrone, and diethone on the respiratory
rates characteristic of state 4 (succinate alone), FCCP-
stimulated respiration (uncoupled respiration), and
ADP-stimulated respiration (state 3) of rat mito-
chondria. State 3 and uncoupled respiration rates were
significantly depressed by cerebrocrast for concen-
trations up to 100 mM, whereas state 4 respiration was
stimulated three times. Gammapyrone, glutapyrone,
and diethone concentrations up to 100 mM were
without significant effect on the respiratory rates.
Fig. 4 shows the effect of cerebrocrast on
mitochondrial transmembrane potential (DC) and
phosphorylation rate developed by succinate-sup-
ported respiration. Cerebrocrast, in the concentration
range up to 25 mM, does not significantly affect DC
developed by succinate-supported respiration. Con-
comitantly, the ADP phosphorylation rate was not
Fig. 2. Effects of cerebrocrast (A), glutapyrone (†), gammapyrone
(W), and diethone (B) on succinate-dependent respiratory indexes
RCR (A) and ADP/O (B) of rat liver mitochondria. Control values
for rat liver mitochondria RCR ¼ 3:9 ^ 0:56; ADP=O ratio ¼
1:98 ^ 0:05. The results correspond to the mean ^ S.E. of four to
six independent experiments. *p , 0:05 compared with the control
(in the absence of compounds).
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changed. At a higher concentration range (up to
100 mM), it induces a DC dissipation that affects the
ADP phosphorylation rate. Partial dissipation of
mitochondrial DC, by the action of the classical
protonophore dinitrophenol (DNP, 10 mM) to values
lower than those induced by cerebrocrast, had a com-
paratively smaller effect on the ADP phosphorylation
rate (Fig. 4), suggesting that cerebrocrast-induced
decrease of phosphorylation rate is related to phenom-
ena in addition to DC dissipation, i.e. concerning
the phosphorylation system (phosphate carrier, ATP-
synthase complex, and/or ATP/ADP carrier). Gam-
mapyrone, glutapyrone, and diethone, in the concen-
tration range up to 100 mM, do not significantly affect
either DC or phosphorylation rate developed by
succinate-supported respiration.
Fig. 5 shows the effect of cerebrocrast on the
mitochondrial phosphate carrier (phosphate2/Hþ
symporter), as evaluated by the passive swelling of
rat liver mitochondria suspended in ammonium
phosphate medium. In the absence of cerebrocrast,
non-respiring mitochondria, suspended in ammonium
phosphate medium swell, spontaneously due to phos-
phate enter in symport with Hþ. In the presence of
cerebrocrast concentrations up to 50 mM, the rate of
mitochondrial swelling decreased in a concentration-
dependent manner. This finding indicates that cere-
brocrast causes a partial inhibition of phosphate
transport and, consequently, depression on the phos-
phorylation rate. However, the inhibitory action of
cerebrocrast on the phosphate carrier per se did not
explain the depression on the phosphorylation rate
observed for concentrations above 50 mM (Fig. 4). In
this concentration range, the effect of cerebrocrast on
the rate of mitochondrial swelling was identical
(Fig. 5). The effect of cerebrocrast on the phosphate
carrier was confirmed by swelling induced by acti-
vation of the phosphate and dicarboxylate carriers, i.e.
by the addition of 5 mM phosphate to non-respiring
mitochondria suspended in potassium malate medium
plus nigericin, as described by Zernig et al. (1990)
(results not shown). Depression of the phosphoryl-
ation rate induced by cerebrocrast in rat liver
mitochondria cannot be attributed to the inhibition
of the ATP-synthase, since the activity of mitochon-
drial ATPase was not significantly affected by
100 mM cerebrocrast (results not shown). The effect
of cerebrocrast on the ATP/ADP carrier was not
evaluated and its involvement in the depression of the
phosphorylation rate induced by this compound
cannot be excluded.
In Fig. 6, we can observe the effect of cerebrocrast
Fig. 3. Effects of cerebrocrast (A), glutapyrone (†), gammapyrone
(W), and diethone (B) on succinate-supported O2 consumption in
state 3 (A), state 4 (B), and uncoupled-respiration (C) of rat liver
mitochondria (when the symbols are not visible, they are
overlapped). The following are the control values for rat liver
mitochondria: state 3 ¼ 68.35 ^ 9.72; state 4 ¼ 13.6 ^ 2.9;
uncoupled respiration ¼ 83.83 ^ 10.11, expressed in nmol O2
(mg protein)21 min21. The results correspond to the mean ^ S.E.
of four independent experiments (when the error bars are not visible,
S.E. is encompassed by the size of the symbols). *p , 0:05
compared with the control (in the absence of compounds).
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on the IMAC, as evaluated by the passive swelling of
rat liver mitochondria suspended in KCl medium,
after activation of IMAC by depleting matrix divalent
cations with the ionophore A23187 (Beavis, 1992). In
the absence of cerebrocrast, non-respiring mitochon-
dria suspended in KCl medium swells very slowly.
The addition of A23187 depletes the matrix of diva-
lent cations and in the presence of nigericin, to induce
the Kþ/Hþ antiport, a small increase in mitochondrial
volume, associated with the net exchange of osmotic-
ally inactive Mg2þ for osmotically active Kþ, indi-
cates the activation of a Cl2 channel. A rapid swelling
is not observed until valinomycin is added to provide
a uniport pathway for Kþ. Thus, in the presence of
sufficient valinomycin to ensure that Kþ transport is
not limiting, the rate of KCl influx and subsequent
swelling should be limited by the rate of Cl2 entry
into mitochondrial matrix via IMAC. Treatment of
mitochondria with cerebrocrast concentrations up to
25 mM inhibited this type of swelling in a concen-
tration-dependent manner indicating that Cl2 trans-
port has been inhibited. The IC50 value, concentration
causing 50% of maximal inhibition, calculated as
previously described (Zernig et al., 1990) for IMAC
inhibition by cerebrocrast was 10.5 ^ 2.0 mM. Inhi-
bition of phosphate uniport by cerebrocrast was
demonstrated, by a similar procedure in a potassium
phosphate medium using mitochondria treated with
N-ethylmaleimide to block the electroneutral trans-
port of phosphate by the phosphate2/Hþ symporter
Fig. 4. Effect of cerebrocrast on mitochondrial transmembrane potential (DC) and phosphorylation rate of rat liver mitochondria supported by
succinate (A) and mitochondrial phosphorylation after partial DC dissipation by dinitrophenol (DNP) as a reference, for the evaluation of
cerebrocrast effects (B). Mitochondria (1 mg) were incubated in 1 ml of the standard respiratory medium supplemented with 2 mM rotenone and
3 mM TPPþ for 3 min at 30 8C in the absence and presence of cerebrocrast (25, 50, 75, and 100 mM), before energization with 10 mM succinate.
The phosphorylation was initiated with the addition of ADP (150 mM). Cer indicates addition of cerebrocrast and DNP, addition of
dinitrophenol. The traces are typical of several independent experiments with four different mitochondrial preparations. Table inserts show the
average response (mean ^ S.E.) of membrane potential developed with succinate, the drop in membrane potential after ADP addition, and the
repolarization value after all the added ADP were phosphorylated. Values statistically different from control (in the absence of cerebrocrast):
*p , 0:05.
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(results not shown). In the same concentration range,
gammapyrone, glutapyrone, and diethone were with-
out effect on both mitochondrial Cl2 and phosphate
uniporters.
The effect of cerebrocrast on Ca2þ-induced open-
ing of mitochondrial PTP was evaluated by following
mitochondrial swelling (Fig. 7). Mitochondria have a
finite capacity to accumulate calcium before under-
going the Ca2þ-dependent mitochondrial perme-
ability transition (Rolo et al., 2000). The Ca2þ
concentration that should be applied to assess the
effect of cerebrocrast on PTP induction was evaluated
and a Ca2þ concentration of 40 mM was selected. In
the absence of cerebrocrast, Ca2þ-loaded, succinate-
energized rat liver mitochondria suspension under-
went a permeability transition, as reflected by the
decrease in absorbance at 520 nm, an effect that was
inhibited completely by prior addition of Cysclo-
porine (CsA). Treatment of mitochondria with
cerebrocrast concentrations up to 25 mM enlarged
the lag time required to exert their effects, but the rate
of swelling was not altered as compared with control
mitochondria. However, the magnitude of the volume
change of mitochondria treated with cerebrocrast
decreased in a concentration-dependent manner. This
finding indicated that the induction of mitochondrial
swelling was not completed and the effect of cere-
brocrast was not only due to the alteration of the time-
constant governing activation of PTP. Cerebrocrast
concentrations higher than 25 mM did not signifi-
cantly protect Ca2þ-induced mitochondrial swelling
(results not shown). This finding is not surprising if
we take into account that cerebrocrast concentrations
Fig. 5. Effect of cerebrocrast on the phosphate carrier, evaluated by
passive swelling of rat liver mitochondria suspended in ammonium
phosphate medium. Mitochondria (1 mg) were suspended in 2.5 ml
of ammonium phosphate medium [135 mM ammonium phosphate,
5 mM HEPES (pH 7.2) and 0.1 mM EDTA] supplemented with
2 mM rotenone at 30 8C in the absence and presence of cerebrocrast
(10, 25, 50, and 100 mM). Mit indicates the addition of mito-
chondria and Cer, addition of cerebrocrast. The traces are typical of
several independent experiments with four different mitochondrial
preparations. Table inserts show the average response (mean ^
S.E.) of the slope of b for the first 60 s. b is a light scattering
variable which normalizes reciprocal absorbance (A 21) for
mitochondrial concentration, P (mg/ml). b ; P=PsðA21 2 aÞ
where P (equals 1 mg/ml) is introduced to make b a scaled
dimensionless quantity and a is a machine constant equal to 0.05
with our apparatus (Beavis and Garlid, 1987). Values statistically
different from control (in the absence of cerebrocrast): **p , 0:005.
Fig. 6. Effect of cerebrocrast on the mitochondrial inner membrane
channel (IMAC), evaluated by passive swelling of rat liver mito-
chondria suspended in KCl medium. Mitochondria (1 mg)
suspended in 2.5 ml of KCl medium [54 mM KCl, 5 mM HEPES
(pH 7.4), 0.1 mM EGTA, and 0.2 mM EDTA] supplemented with
2 mM rotenone were incubated for 3 min at 30 8C in the absence and
presence of cerebrocrast (2.5, 5, 10, and 25 mM). At the end of the
incubation period, nigericin (1 nmol/mg protein) was added
followed by the addition of A23187 (10 nmol/mg protein) and
valinomycin (1 nmol/mg protein) 2 and 4 min later, respectively. In
all the assays, nigericin and A23187 were present; (—) assays
performed in the presence of valinomycin and (- - - - -) assay
performed in the absence of valinomycin and cerebrocrast. Nig,
A23187, and Val, indicate the additions of nigericin, A23187, and
valinomycin, respectively. The traces are typical of several
independent experiments with four different mitochondrial
preparations.
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higher than 25 mM cause mitochondrial uncoupling
(Figs. 2 and 4), an effect that potentiates PTP by itself.
Although the uncoupling action of high concen-
trations of cerebrocrast ($25 mM) likely limits its
potential protective effect in vivo, the partial protec-
tive action of low concentrations of cerebrocrast
(#25 mM) observed in rat liver mitochondria (Fig. 7)
could be related to the neuroprotective action of low
doses of cerebrocrast administered to rats and mice
in vivo (0.005–0.05 mg kg21 i.p., i.v., and p.o.)
(Klusa, 1995). Gammapyrone, glutapyrone, and
diethone were without effect on Ca2þ-induced PTP.
Fig. 8 shows the effect of different concentrations
of diethone on oxygen consumption (A), TBARS
formation (B), and DC dissipation (C) due to lipid
peroxidation initiated by the oxidant pair ADP/Fe2þ
in rat liver mitochondria. In the absence of diethone
and after the addition of ADP/Fe2þ, it is possible to
distinguish a two-phase kinetics in oxygen consump-
tion: an initial, slow oxygen consumption lag phase
lasting about 1 min is followed by a rapid oxygen
consumption phase. The lag phase is considered to be
the time required for the generation of a sufficient
amount of the perferryl ion complex (ADP–Fe2þ–
O2 $ ADP–Fe3þ–O22) which has been suggested to
be responsible for the initiation of lipid peroxidation.
The rapid oxygen consumption phase is probably due
to the oxidation of the polyunsaturated fatty acid acyl
chain of membrane phospholipids by ROS and,
consequently, to the propagation phase of lipid
peroxidation (Sassa et al., 1990). Diethone concen-
trations up to 5 mM enlarge the slow oxygen
consumption lag phase/lag time, before oxygen
uptake burst induced by the complex ADP/Fe2þ, but
were without significant effect on the rapid oxygen
consumption phase. At 5 mM diethone, a complete
lipid peroxidation inhibition is observed.
The quantitative evaluation of TBARS formation,
induced by ADP/Fe2þ, was performed to confirm the
clear antioxidant effect of diethone also observed by
oxygen consumption. Fig. 8B shows that the kinetics
of TBARS formation induced by ADP/Fe2þ is similar
to that observed for oxygen consumption. TBARS
formation was inhibited in the same range of
diethone concentrations observed to inhibit oxygen
consumption.
The effect of diethone on DC dissipation, due to
liver mitochondrial membranes lipid peroxidation,
initiated by ADP/Fe2þ after mitochondrial energiz-
ation with succinate, was also evaluated (Fig. 8C).
The energization of mitochondria was carried out in
the presence of oligomycin, a specific inhibitor of
mitochondrial ATP synthase to avoid the membrane
depolarization that follows ADP/Fe2þ addition. Upon
succinate energization and in the absence of ADP/
Fe2þ, mitochondria built up and sustained a DC close
Fig. 7. Effect of cerebrocrast on Ca2þ-induced opening of mitochondrial PTP, evaluated by passive mitochondrial osmotic swelling.
Mitochondria (1 mg) suspended in 2.5 ml of an osmotic medium containing 200 mM sucrose, 10 mM HEPES–Tris (pH 7.4), 1 mM KH2PO4,
and 10 mM EGTA supplemented with 2 mM rotenone and 0.5 mg/ml oligomycin were incubated for 3 min at 30 8C in the absence and presence
of cerebrocrast (10 and 25 mM). At the end of the incubation period, 5 mM succinate was added and the experiments were started by the addition
of 40 mM Ca2þ, 2 min later. When indicated, 1 mM Cyclosporine A (CsA) was included in the reaction medium prior the addition of succinate
and Ca2þ. The traces are typical of several independent experiments with four different mitochondrial preparations.
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to2200 mV for more than 15 min. After the addition
of ADP/Fe2þ, a lag phase was observed that, similar
to what happened with oxygen consumption, repre-
sents the time required to generate a sufficient amount
of ROS responsible for the initiation of lipid per-
oxidation. After this lag phase, the DC underwent a
rapid decline, probably associated with the disruption
of mitochondrial membrane promoted by lipid
peroxidation. Diethone increased the depolarization
lag phase in a dose-dependent manner, but it was
without effect on the rapid decline of the DC. It is
important to note that maximum protection with
diethone on DC was attained in the concentration
range up to 5 mM, where it shows a maximum anti-
oxidant capability, as determined by the quantification
of TBARS and oxygen consumption. Cerebrocrast,
gammapyrone, and glutapyrone concentrations up to
100 mM did not affect ADP/Fe2þ-induced lipid
peroxidation of rat liver mitochondria, as confirmed
by the parameters used to evaluate lipid peroxidation.
4. Discussion
In this study, we investigated whether four
structurally different DHP derivatives (cerebrocrast,
gammapyrone, glutapyrone, and diethone), at the
concentration range showing no interference with
mitochondrial bioenergetics, can protect mitochon-
dria against oxidative stress.
One of the main findings was the observation that,
from the four compounds tested, cerebrocrast is the
only compound that affects mitochondrial bioener-
getics, but only at concentrations higher than 25 mM,
as shown by the following parameters: decrease of the
succinate-dependent respiratory indexes (RCR and
ADP/O) (Fig. 2); inhibition of oxygen-supported
respiration in state 3 and uncoupled respiration
(Fig. 3) with parallel DC dissipation (Fig. 4) and
decrease of the phosphorylation efficiency (Fig. 4);
inhibition of the phosphate carrier (Fig. 5) and
stimulation of oxygen-supported respiration in state
4 (Fig. 4). These data suggested that cerebrocrast at
high concentrations ($25 mM) exhibited a toxic
action. The toxic action of cerebrocrast, as evaluated
by its interference with mitochondrial bioenergetics,
fits well with toxicity evaluated by its LD50 values 450
(357–567) mg kg21 i.p. and 730 (570–934) mg kg21
p.o. in mice (Misa˜ne et al., 1993).
Other main finding was the observation that
cerebrocrast, at concentrations that did not interfere
with mitochondrial bioenergetics (#25 mM), was
also the only compound that had the capacity to
inhibit IMAC (Fig. 6). This effect of cerebrocrast is
not surprising if we take into account that its structure
is more related to the Ca2þ antagonist structure of
Fig. 8. Effect of diethone on mitochondrial oxidative damage (lipid
peroxidation) induced by the oxidant pair ADP/Fe2þ. Lipid
peroxidation was evaluated by oxygen consumption (A), TBARS
assay (B), and DC (C). The traces in (A) and (B) represent typical
direct recordings representative of four to six independent experi-
ments with different mitochondrial preparations. The data in (B)
correspond to the mean ^ S.E. of four to six independent experi-
ments. *p , 0:05, ***p , 0:0001 compared with mitochondria
submitted to ADP/Fe2þ treatment (B) in the absence of diethone.
þþþp , 0:0001 compared with mitochondria not submitted to
ADP/Fe2þ treatment (G).
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DHPs class, well known inhibitors of IMAC (Zernig
et al., 1990) than to the other three compounds (Fig. 1).
Also, the IC50 value for IMAC inhibition by
cerebrocrast ðIC50 ¼ 10:5 ^ 2:0Þ is similar to
those reported for nicardipine ðIC50 ¼ 8:4 ^ 0:4Þ,
niludipine ðIC50 ¼ 8:7 ^ 0:8Þ, and nisoldipine
ðIC50 ¼ 12 ^ 2:7Þ, well known Ca2þ antagonist of
DHPs class (Zernig et al., 1990). IMAC, which is
inhibited by matrix Mg2þ and Hþ, only appears to
conduct ions under low divalent ions matrix concen-
trations and alkaline matrix conditions, being unclear
what its physiological role is or if it opens under
pathophysiological conditions (O’Rourke, 2000).
However, it has been suggested to be an important
safeguard against mitochondrial swelling, as it is
poised to counteract the influx of cations (Beavis,
1992). Accordingly, Zernig et al. (1990) proposed that
the inhibition of IMAC by Ca2þ antagonists (DHPs,
phenylalkylamines, and benzothiazepines) could inhi-
bit excessive Ca2þ uptake by mitochondria, prevent-
ing the resulting structural and functional impairment.
In agreement with this proposition, the partial
protective action of low concentrations of cerebro-
crast (#25 mM) on Ca2þ-induced PTP (Fig. 7) may
be a consequence of its inhibitory action on the
transport of phosphate via IMAC (results not shown),
thus, preventing excessive Ca2þ accumulation inside
mitochondria and, consequently, decreasing their
susceptibility to PTP induction. The importance of
the interaction of cerebrocrast with IMAC is sup-
ported by a recent suggestion that some of the effects
of Ca2þ antagonists, including the neuroprotective
and anticonvulsant effects of DHPs (nifedipine,
nitrendipine, nicardipine, and (R)-Bay K 8644),
might result partly from their interactions with
ligand-gated chloride channels (Chesnoy-Marchais
and Cathala, 2001) and also by the finding showing
that inhibitors of IMAC (e.g. amiodarone, amitriptly-
line, tributyltin, propanolol, and PK11195, a periph-
eral benzodiazepine receptor inhibitor) are able to
suppress the mitochondrial oscillations namely,
periodic rapid oxidation of mitochondrial flavo-
proteins and the collapse of DC, induced in intact
cardiomyocytes under metabolic stress (O’Rourke,
2000). Metabolic stress causes oxidative stress in
human breast carcinoma MCF-7/ADR cells (Lee et al.,
1998), an effect that has been suggested to be related
to ROS production by mitochondria during glucose
deprivation (Spitz et al., 2000; Lee et al., 2001).
Therefore, inhibitors of IMAC, including cerebro-
crast, may be of great value in the treatment of several
pathological situations known to be associated with
cellular oxidative stress.
Another point of interest was the finding that
gammapyrone, glutapyrone, and cerebrocrast did not
protect rat liver mitochondria against oxidative
damage induced by the oxidant pair ADP/Fe2þ,
while diethone could protect in a dose-dependent
manner (Fig. 8). This effect is probably due to the
prevention of the formation of ROS derived from
ADP/Fe2þ, namely, the perferryl ion complex ADP–
Fe3þ–O2
2, which has been suggested to be respon-
sible for the initiation phase of lipid peroxidation,
analyzed as the lag time that accompanies the oxygen
uptake burst and the collapse of DC (Fig. 8).
Mitochondrial membranes were used to demonstrate
the antioxidant activity of diethone because they are
particularly susceptible to oxidative damage due to its
high content in polyunsaturated fatty acids (Halliwell
and Gutteridge, 1999; Kowaltowski and Vercesi,
1999) and proximity to the ROS generated in the
electron transport chain (Lee and Wei, 2000; Murphy
and Smith, 2000; Pedersen, 2000). Mitochondrial
oxidative damage causes alterations in structural
integrity of mitochondrial membranes that lead to
DC dissipation, depletion of cellular ATP, and cell
death (Kowaltowski and Vercesi, 1999). Previous
studies demonstrated that preservation of mitochon-
drial DC is critical to maintain cell integrity (Carini
et al., 1990). Therefore, diethone, by preventing the
disruption of mitochondrial DC that follows per-
oxidative alterations, might protect mitochondrial
function thus preventing irreversible cell injury in
pathological situations associated with cellular oxi-
dative stress. The results obtained in this study are
quite consistent with previous findings showing that
diethone, under the same concentration range, exhi-
bits antioxidant properties in rat liver mitochondria,
expressed as the enlargement of the induction period/
lag time before mitochondrial swelling and oxygen
uptake burst induced by the complex ADP/Fe2þ in the
presence of ascorbate (reducing equivalent), which
corresponds to the inhibition of the initiation of lipid
peroxidation (Velena et al., 1999). At small concen-
trations (comparable with pharmacological active
ones), diethone has been shown to inhibit Fe2þ
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initiated lipid peroxidation, not only in mitochondria
but also in isolated rat liver microsomes. In phospha-
tidylcholine liposomes, when lipid peroxidation was
initiated by methemoglobine and in emulsions of
linethole, if this initiation was made in the presence of
the heme compounds hemine, hematine, and cyto-
chrome c, the antioxidant effect of diethone was also
observed (Abdalla et al., 1999; Velena et al., 1999).
The comparison of the effects of cerebrocrast,
gammapyrone, glutapyrone, and diethone on mito-
chondria bioenergetics, IMAC, Ca2þ-induced open-
ing of PTP, and oxidative damage induced by
ADP/Fe2þ, clearly showed that none of the com-
pounds interfere with mitochondrial bioenergetics at
concentrations lower than 25 mM; cerebrocrast was
the only compound that affected mitochondrial bio-
energetics, but only for concentrations higher than
25 mM; at concentrations that did not affect mito-
chondrial bioenergetics (#25 mM), only cerebrocrast
inhibited the IMAC and partially prevented Ca2þ-
induced opening of the PTP; diethone was the only
compound that expressed antioxidant activity at very
low concentrations (#5 mM). The different effects of
cerebrocrast and diethone cannot be attributed to
differences on their lipid solubility since they are both
lipophilic compounds (Misa˜ne et al., 1993; Klusa,
1995; Velena et al., 1997, 1999). The apparent
partition coefficient of cerebrocrast, log P ¼ 4:96
(octanol/water) (Tirzite, personal communication)
and that of diethone, log P . 2 (linethole/phosphate
buffer pH 7.5) (Kumsars et al., 1971) favor the
presence of these molecules in the bulk phase of
biological membranes. The different effects of
cerebrocrast and diethone on mitochondria might be
related with differences on their molecular structure
(Fig. 1). The interference of cerebrocrast with
mitochondrial function may be related with the 2-
difluoro-methoxyphenyl ring, which is joined to DHP
at position 4 in combination with the medium length
2-propoxyethyl side chains with oxa atoms in
positions 3 and 5 of the DHP ring. The potent
antioxidant capacity of diethone is probably related to
the non-substituted methylene group, having two
hydrogen atoms in position 4 of the DHP molecule,
capable of being proton donors.
In conclusion, in this study, we found that among
the DHP derivatives (cerebrocrast, gammapyrone,
glutapyrone, and diethone) examined, cerebrocrast
acting as an inhibitor of IMAC and diethone, acting as
an antioxidant, could provide effective protective
roles in preventing mitochondria from oxidative
damage, favoring their therapeutic interest in the
treatment of several pathological situations known to
be associated with cellular oxidative stress. Studies
using whole animals or organs (i.e. in vivo or ex vivo
organ function studies) and cultured cells (i.e. in vitro
energy metabolism studies), as well as studies with
other potent lipophilic antioxidants, deserve further
investigation to validate the relevance of the effects of
cerebrocrast and diethone on isolated mitochondria
function.
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